As soon as babies are born, they are susceptible to diseases and infections, such as jaundice and E. coli. For up to a month, their immune systems aren't adequately developed to fight diseases.
Researchers work on vaccine to improve immune system in newborns
Emergent BioSolutions acquires Europe’s Microscience
Fuad El-Hibri
GAITHERSBURG, Md. — Emergent BioSolutions announced that it acquired England-based Microscience Ltd., a privately held vaccine company primarily involved in the research and development of proprietary vaccines and immunotherapeutics.
Browse by Category
Browse by Location
Search
Tag Cloud
H1N1 National Institutes of Health Human papillomavirus Harvard School of Public Health FDA Influenza Emergency preparedness MRSA anthrax Bio-Rescue Gates Foundation research grants immunization AIDS CDC MIND Institute mercury autism Health Canada HHS Infectious disease Measles Tuberculosis Malaria smallpox research pneumonia NIAID NIFA Defense Dept Streptococcus kala azar food safety Dengue fever Cancer typhoid E. coli hepatits polio Ebola dna technology antibiotics Mumps Alzheimer's Yellow Fever pneumococcal disease HIB Pertussis Tetanus diptheria prevention Bioweapons Avian flu rotavirus Reaction Shingles tracking Detection technology Travelers’ Diarrhea gum disease C difficile jaundice meningitis nasal vaccine HSV2 Chlamydia needle-free foot and mouth disease leukemia chicken pox cervical cancer rsv Staphylococcus aureus scarification Helicobacter cholera Prostate Cancer salmonella Rubella chikungunya virus SV40 smoking tropical diseases whooping cough SARS ragweed pancreatic cancer retrovirus rheumatoid arthritis H5N1 Pharmaceuticals vitamins
Subscribe to our newsletter
RSS Feed
